Parkinson's patients monitored as experimental brain treatment winds down
NCT ID NCT07214285
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 29 times
Summary
This study follows one Parkinson's patient who has been receiving A-dopamine directly into the brain for years. The goal is to track safety and gradually reduce the dose to avoid sudden停药, switching to an alternative treatment if needed. It focuses on managing the transition rather than curing the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UHLillle
Lille, Haut de France, 59000, France
Conditions
Explore the condition pages connected to this study.